Literature DB >> 24709807

Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography.

Dawn A Sim1, Pearse A Keane2, Ranjan Rajendram2, Michael Karampelas3, Senthil Selvam4, Michael B Powner4, Marcus Fruttiger4, Adnan Tufail2, Catherine A Egan3.   

Abstract

PURPOSE: To investigate the association between peripheral and central ischemia in diabetic retinopathy.
DESIGN: Retrospective, cross-sectional.
METHODS: Consecutive ultra-widefield fluorescein angiography images were collected from patients with diabetes over a 12-month period. Parameters quantified include the foveal avascular zone (FAZ) area, peripheral ischemic index, peripheral leakage index, and central retinal thickness measurements, as well as visual acuity. The peripheral ischemia or leakage index was calculated as the area of capillary nonperfusion or leakage, expressed as a percentage of the total retinal area.
RESULTS: Forty-seven eyes of 47 patients were included. A moderate correlation was observed between the peripheral ischemia index and FAZ area (r = 0.49, P = .0001). A moderate correlation was also observed between the peripheral leakage index and FAZ area, but only in eyes that were laser naïve (r = 0.44, P = .02). A thinner retina was observed in eyes with macular ischemia (217 ± 81.8 μm vs 272 ± 36.0 μm) (P = .02), but not peripheral ischemia (258 ± 76.3 μm vs 276 ± 68.0 μm) (P = .24). The relationships between different patterns of peripheral and central macular pathology and visual acuity were evaluated in a step-wise multivariable regression model, and the variables that remained independently associated were age (r = 0.33, P = .03), FAZ area (r = 0.45, P = .02), and central retinal thickness (r = 0.38, P = .01), (R(2)-adjusted = 0.36).
CONCLUSIONS: Ultra-widefield fluorescein angiography provides an insight into the relationships between diabetic vascular complications in the retinal periphery and central macula. Although we observed relationships between ischemia and vascular leakage in the macula and periphery, it was only macular ischemia and retinal thinning that was independently associated with a reduced visual function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24709807     DOI: 10.1016/j.ajo.2014.03.009

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  35 in total

1.  Ultra-Widefield Protocol Enhances Automated Classification of Diabetic Retinopathy Severity with OCT Angiography.

Authors:  FuPeng Wang; Steven S Saraf; Qinqin Zhang; Ruikang K Wang; Kasra A Rezaei
Journal:  Ophthalmol Retina       Date:  2019-11-09

2.  Quantitative Ultra-Widefield Angiographic Features and Associations with Diabetic Macular Edema.

Authors:  Alice C Jiang; Sunil K Srivastava; Ming Hu; Natalia Figueiredo; Amy Babiuch; Joseph D Boss; Jamie L Reese; Justis P Ehlers
Journal:  Ophthalmol Retina       Date:  2019-08-28

3.  The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography.

Authors:  Fares Antaki; Razek Georges Coussa; Mikel Mikhail; Cyril Archambault; David E Lederer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-07-16       Impact factor: 3.117

Review 4.  Optical coherence tomography angiography (OCTA) flow speed mapping technology for retinal diseases.

Authors:  Malvika Arya; Ramy Rashad; Osama Sorour; Eric M Moult; James G Fujimoto; Nadia K Waheed
Journal:  Expert Rev Med Devices       Date:  2018-11-22       Impact factor: 3.166

5.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

Review 6.  Diabetic macular ischemia.

Authors:  Beatrice Tombolini; Enrico Borrelli; Riccardo Sacconi; Francesco Bandello; Giuseppe Querques
Journal:  Acta Diabetol       Date:  2022-02-08       Impact factor: 4.280

Review 7.  Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy.

Authors:  Irini Chatziralli; Sara Touhami; Maria Vittoria Cicinelli; Chrysa Agapitou; Eleni Dimitriou; George Theodossiadis; Panagiotis Theodossiadis
Journal:  Eye (Lond)       Date:  2021-08-18       Impact factor: 3.775

8.  Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.

Authors:  Paolo S Silva; Dennis M Marcus; Danni Liu; Lloyd Paul Aiello; Andrew Antoszyk; Michael Elman; Scott Friedman; Adam R Glassman; Joseph M Googe; Lee Merrill Jampol; Daniel F Martin; Michele Melia; Carin M Preston; Charles C Wykoff; Jennifer K Sun
Journal:  JAMA Ophthalmol       Date:  2022-10-01       Impact factor: 8.253

9.  Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.

Authors:  Natalia Figueiredo; Sunil K Srivastava; Rishi P Singh; Amy Babiuch; Sumit Sharma; Aleksandra Rachitskaya; Katherine Talcott; Jamie Reese; Ming Hu; Justis P Ehlers
Journal:  Ophthalmol Retina       Date:  2019-09-10

10.  Comparison of automated and expert human grading of diabetic retinopathy using smartphone-based retinal photography.

Authors:  Tyson N Kim; Michael T Aaberg; Patrick Li; Jose R Davila; Malavika Bhaskaranand; Sandeep Bhat; Chaithanya Ramachandra; Kaushal Solanki; Frankie Myers; Clay Reber; Rohan Jalalizadeh; Todd P Margolis; Daniel Fletcher; Yannis M Paulus
Journal:  Eye (Lond)       Date:  2020-04-27       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.